Kensei Yamaguchi

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Kensei Yamaguchi

Nov 27, 2024, 20:08 | Blog

Important biomarker analyses for T-DXd in HER2-expressing Metastatic colorectal cancer

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: "Important biomarker analyses…

Sep 24, 2024, 12:30 | Societies

11 ESMO24 presentations published on NEJM

At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…

Aug 7, 2024, 00:27 | Blog

Paolo Tarantino reflects on the results from DESTINY-CRC02 published in the Lancet Oncology

Paolo Tarantino shared on X: “Results from DESTINY-CRC02 published in the Lancet Oncology. Among patients…

Jun 18, 2024, 07:07 | Insight

Tislelizumab plus chemotherapy in advanced gastric/GEJ adenocarcinoma

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Tislelizumab plus chemotherapy vs…

All: 4 Posts: 1 - 100

'

April is Head and Neck Cancer Awareness Month

'

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

'

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

'

Cancer Center Near Me: Dana-Farber Cancer Institute

'

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023